# FDA 483 - Claudia T. Martorell, M.D. - June 15, 2026

Source: https://www.keypedia.com/records/483/claudia-t-martorell-md/8f0c5f71-3aaf-444c-b1b9-8a43ebb2bd3d

> FDA 483 for Claudia T. Martorell, M.D. on June 15, 2026. Product: other. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Claudia T. Martorell, M.D.
- Inspection Date: 2026-06-15
- Product Type: other
- Office Name: New England District Office
- Summary: An FDA inspection of Claudia T. Martorell, M.D., a clinical investigator in Springfield, MA, identified a significant deviation from an investigational plan. The firm enrolled and dosed a subject who did not meet the required plasma level at screening, indicating a failure to adhere to inclusion criteria. This observation highlights issues with protocol compliance in clinical investigations.

## Related Officers

- [Agata E. Libera](https://www.keypedia.com/people/agata-e-libera/ab9679b1-cd55-452e-bdf3-dd22f67f4e0c)
- [Meredith L. Miller](https://www.keypedia.com/people/meredith-l-miller/c775003b-4e5b-48d8-bc51-1a3ebe813dba)

Company: https://www.keypedia.com/companies/claudia-t-martorell-md/71a9a478-c435-43cb-81e2-195a2bf328f7

Office: https://www.keypedia.com/offices/new-england-district-office/aa458072-2f1d-4231-89f5-21ba7a3b7144